Biotech stocks are experiencing significant moves in pre-market activity on Tuesday, indicating potential trading opportunities.
By evaluating sentiment and momentum before the bell, premarket analysis becomes a foundational step in any trader's pre market routine.
In the Green - Premarket Gainers
On Tuesday, the following stocks are trading significantly higher in the premarket session.
1. Heron Therapeutics Inc. (HRTX) - up 12% at $1.322. Exact Sciences Corp. (EXAS) - up 10% at $ 73.763. Nanobiotix SA - ADR. (NBTX) - up 8% at $19.044. Biodesix Inc. (BDSX) - up 8% at $6.835. Terns Pharmaceuticals Inc. (TERN) - up 7% at $15.06. Henry Schein Inc. (HSIC) - up 5% at $68.017. NextCure Inc. (NXTC) - up 3% at $ $12.348. Dyne Therapeutics Inc. (DYN) - up 3% at $24.809. Madrigal Pharmaceuticals Inc. (MDGL) - up 2% at $420.1910. Pyxis Oncology Inc. (PYXS) - up 1% at $3.83
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.